NanoKar Therapeutics
ITAM-Optimized Cell Therapy Platform
NanoKar Therapeutics discovered that chimeric antigen receptors function as mechanosensors, and developed a platform to engineer them. Our patent-pending ITAM optimization technology tunes the intracellular signaling of…


